Back to Results

Shoulder Innovations Inc (SI)

Shoulder Innovations, Inc. is a healthcare equipment company focused on shoulder arthroplasty implant systems in the United States. Its product development includes InSet Glenoid technology, which is designed to help lower mechanical stress at the bone-implant interface, support fixation mechanics, improve stability, and reduce micromotion. The company was incorporated in 2009 and is based in Grand Rapids, Michigan. Shares of Shoulder Innovations are listed as common stock on the NYSE under the ticker SI.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-SI
$12.86
-34.6% Downside
Overvalued
$26.50
34.8% Upside
Undervalued
Good
0.0%
November 5, 2026
3.3x
6.8x
409.3 M
325.2 M
3.5%
51.7%
8.5
134.4%
Valuation • Fair Value

Shoulder Innovations Inc (NYSE-SI) Fair Value by Valuation Model

Review the available estimates for Shoulder Innovations Inc (NYSE-SI), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$12.86

Estimated downside of 34.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$10.31

Discounted cash flow valuation reference.

EPV Fair Value

$10.50

Earnings power value estimate.

Comps Fair Value

$14.10

Comparable-company valuation reference.

Analyst Price Target

$26.50

Analysts imply upside of 34.8%.

How to read these valuation models

Use the 6 available valuation references for Shoulder Innovations Inc (NYSE-SI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Shoulder Innovations Inc (NYSE-SI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

60.055 M

Current operating scale indicator.

Revenue Forecast

68.341 M

Forward revenue estimate.

EBITDA

-31.315 M

Current operating profitability reference.

EBITDA Forecast

-31.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Shoulder Innovations Inc (NYSE-SI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Shoulder Innovations Inc (NYSE-SI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.13

Intermediate zone that deserves monitoring.

Altman Z-Score

8.5

Relatively strong balance-sheet zone.

FCF / Net Income

134.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Shoulder Innovations Inc (NYSE-SI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Shoulder Innovations Inc (NYSE-SI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

12

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Shoulder Innovations Inc (NYSE-SI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Shoulder Innovations Inc (NYSE-SI) Stock Forecast & Technical Outlook

Review Shoulder Innovations Inc (NYSE-SI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Shoulder Innovations Inc (NYSE-SI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Shoulder Innovations Inc (NYSE-SI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Shoulder Innovations Inc (NYSE-SI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Shoulder Innovations Inc (NYSE-SI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Shoulder Innovations Inc (NYSE-SI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Shoulder Innovations Inc (NYSE-SI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Shoulder Innovations Inc (NYSE-SI) has a Strong Buy consensus, with 3 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 3
Hold 0
Sell 0
FAQ • Fast Investor Answers

Shoulder Innovations Inc (NYSE-SI) Stock FAQ

Data-supported answers about Shoulder Innovations Inc (NYSE-SI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$12.86
Estimated downside 34.6%
Valuation Rating
Overvalued
Estimated downside of 34.6%
Analyst Target
$26.50
Implied upside 34.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Shoulder Innovations Inc (NYSE-SI) is $12.86. This implies an estimated downside of 34.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 34.6% versus the current market price.

The available analyst price target for Shoulder Innovations Inc (NYSE-SI) is $26.50. The analyst target implies estimated upside of 34.8%.

The current financial health read for Shoulder Innovations Inc (NYSE-SI) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Shoulder Innovations Inc (NYSE-SI) is November 5, 2026.

The latest available data indicates no current dividend yield for Shoulder Innovations Inc (NYSE-SI).

The current market capitalization listed for Shoulder Innovations Inc is 409.3 M.

The current enterprise value listed for Shoulder Innovations Inc is 325.2 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Shoulder Innovations Inc is NYSE-SI, and the stock is listed on NYSE.

Shoulder Innovations Inc (NYSE-SI) is listed on NYSE.

The current debt-to-total-capital ratio listed for Shoulder Innovations Inc is 3.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Shoulder Innovations Inc is 51.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 156.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 117.8 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.8 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 66.215 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 54.18 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.34 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.818 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 44.147 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 35.562 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 33.943 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 32.273 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 29.411 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 26.348 B
STE NYSE STERIS plc Fair Value Fair Market Cap 22.635 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 18.799 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.539 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.08 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 12.906 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.778 B